Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Pili

Showing results (21-30 of 223) with videos related to

Pageof 23
Sort By:
Cancer Letters|December 30, 2008
Targeting tumor angiogenesis with histone deacetylase inhibitorsLeigh Ellis, Hans Hammers, Roberto Pili
Epigenomics|March 8, 2016
Histone deacetylase inhibitors as immunomodulators in cancer therapeuticsLi Shen, Ashley Orillion, Roberto Pili
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2026
EPR26-186: A Systematic Review and Meta-Analysis of the Association Between Dietary Protein Consumption and Cancer MortalityLauryn Rudin, Roberto Pili, Poolakkad S Satheeshkumar
Asian Journal of Urology|August 29, 2022
Gene expression profiles and treatments for metastatic renal cell carcinoma: What does still need to be defined?Emilio F Giunta, Pasquale Rescigno, Roberto Pili
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2012
Modulation of chemotherapeutic efficacy by vascular disrupting agents: optimizing the sequence and scheduleEunice S Wang, Roberto Pili, Mukund Seshadri
Journal of the National Comprehensive Cancer Network : JNCCN|April 16, 2026
EPR26-186: A Systematic Review and Meta-Analysis of the Association Between Dietary Protein Consumption and Cancer MortalityLauryn Rudin, Roberto Pili, Poolakkad S Satheeshkumar
Investigational New Drugs|August 26, 2014
An open-label study to determine the maximum tolerated dose of the multitargeted tyrosine kinase inhibitor CEP-11981 in patients with advanced cancerRoberto Pili, Michael Carducci, Peter Brown, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 29, 2026
HSR26-230: Machine Learning Models Predict Depression Among Pancreatic and Head and Neck CancersShaniza Haniff, Sreelakshmi Panginikkode, Roberto Pili, et al.
Current Gerontology and Geriatrics Research|December 25, 2018
Ageing, Disability, and Spinal Cord Injury: Some Issues of AnalysisRoberto Pili, Luca Gaviano, Lorenzo Pili, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2026
HSR26-230: Machine Learning Models Predict Depression Among Pancreatic and Head and Neck CancersShaniza Haniff, Sreelakshmi Panginikkode, Roberto Pili, et al.
Pageof 23

Showing results (21-30 of 223) with videos related to

Sort By:
Pageof 23
Cancer Letters|December 30, 2008
Targeting tumor angiogenesis with histone deacetylase inhibitorsLeigh Ellis, Hans Hammers, Roberto Pili
Epigenomics|March 8, 2016
Histone deacetylase inhibitors as immunomodulators in cancer therapeuticsLi Shen, Ashley Orillion, Roberto Pili
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2026
EPR26-186: A Systematic Review and Meta-Analysis of the Association Between Dietary Protein Consumption and Cancer MortalityLauryn Rudin, Roberto Pili, Poolakkad S Satheeshkumar
Asian Journal of Urology|August 29, 2022
Gene expression profiles and treatments for metastatic renal cell carcinoma: What does still need to be defined?Emilio F Giunta, Pasquale Rescigno, Roberto Pili
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2012
Modulation of chemotherapeutic efficacy by vascular disrupting agents: optimizing the sequence and scheduleEunice S Wang, Roberto Pili, Mukund Seshadri
Journal of the National Comprehensive Cancer Network : JNCCN|April 16, 2026
EPR26-186: A Systematic Review and Meta-Analysis of the Association Between Dietary Protein Consumption and Cancer MortalityLauryn Rudin, Roberto Pili, Poolakkad S Satheeshkumar
Investigational New Drugs|August 26, 2014
An open-label study to determine the maximum tolerated dose of the multitargeted tyrosine kinase inhibitor CEP-11981 in patients with advanced cancerRoberto Pili, Michael Carducci, Peter Brown, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 29, 2026
HSR26-230: Machine Learning Models Predict Depression Among Pancreatic and Head and Neck CancersShaniza Haniff, Sreelakshmi Panginikkode, Roberto Pili, et al.
Current Gerontology and Geriatrics Research|December 25, 2018
Ageing, Disability, and Spinal Cord Injury: Some Issues of AnalysisRoberto Pili, Luca Gaviano, Lorenzo Pili, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2026
HSR26-230: Machine Learning Models Predict Depression Among Pancreatic and Head and Neck CancersShaniza Haniff, Sreelakshmi Panginikkode, Roberto Pili, et al.
Pageof 23